All Stories

  1. Glycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment?
  2. Knockdown of STEAP1 inhibits cell growth and induces apoptosis in LNCaP prostate cancer cells counteracting the effect of androgens
  3. Targeting STEAP1 Protein in Human Cancer: Current Trends and Future Challenges
  4. Variability of MMP/TIMP and TGF-β1 Receptors throughout the Clinical Progression of Chronic Venous Disease
  5. The stem cell factor (SCF)/c-KIT system in carcinogenesis of reproductive tissues: What does the hormonal regulation tell us?
  6. The protective effect of regucalcin against radiation-induced damage in testicular cells
  7. The Emerging Role of Regucalcin as a Tumor Suppressor: Facts and Views
  8. Endogenous Factors in the Recovery of Reproductive Function After Testicular Injury and Cancer
  9. Liver diseases: what is known so far about the therapy with human amniotic membrane?
  10. Effect of TGF-beta1 on MMP/TIMP and TGF-beta1 receptors in great saphenous veins and its significance on chronic venous insufficiency
  11. Oligoadenylate synthetase 1 (OAS1) expression in human breast and prostate cancer cases, and its regulation by sex steroid hormones
  12. Oxidative Stress, DNA, Cell Cycle/Cell Cycle Associated Proteins and Multidrug Resistance Proteins: Targets of Human Amniotic Membrane in Hepatocellular Carcinoma
  13. Advances in time course extracellular production of human pre-miR-29b from Rhodovulum sulfidophilum
  14. Estrogens down-regulate the stem cell factor (SCF)/c-KIT system in prostate cells: Evidence of antiproliferative and proapoptotic effects
  15. Aging-associated changes in oxidative stress, cell proliferation, and apoptosis are prevented in the prostate of transgenic rats overexpressing regucalcin
  16. Suppressed glycolytic metabolism in the prostate of transgenic rats overexpressing calcium-binding protein regucalcin underpins reduced cell proliferation
  17. Selective cytotoxicity and cell death induced by human amniotic membrane in hepatocellular carcinoma
  18. Effect of extracellular calcium on regucalcin expression and cell viability in neoplastic and non-neoplastic human prostate cells
  19. 5α-Dihydrotestosterone regulates the expression of L-type calcium channels and calcium-binding protein regucalcin in human breast cancer cells with suppression of cell growth
  20. Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes
  21. Paradoxical and contradictory effects of imatinib in two cell line models of hormone-refractory prostate cancer
  22. Evaluation of MutS and Mut+ Pichia pastoris Strains for Membrane-Bound Catechol-O-Methyltransferase Biosynthesis
  23. Biochemical Properties of Amniotic Membrane
  24. Histopathological and in vivo evidence of regucalcin as a protective molecule in mammary gland carcinogenesis
  25. Hormonal regulation of c-KIT receptor and its ligand: implications for human infertility?
  26. Trends in Protein-Based Biosensor Assemblies for Drug Screening and Pharmaceutical Kinetic Studies
  27. Evaluation of the prebiotic potential of arabinoxylans from brewer’s spent grain
  28. Regucalcin is an androgen-target gene in the rat prostate modulating cell-cycle and apoptotic pathways
  29. Expression of STEAP1 and STEAP1B in prostate cell lines, and the putative regulation of STEAP1 by post-transcriptional and post-translational mechanisms
  30. Improved Minicircle DNA Biosynthesis for Gene Therapy Applications
  31. Effect of Amniotic Membrane Proteins in Human Cancer Cell Lines: An Exploratory Study
  32. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score
  33. Pichia pastoris: A Recombinant Microfactory for Antibodies and Human Membrane Proteins
  34. The diverse roles of calcium-binding protein regucalcin in cell biology: from tissue expression and signalling to disease
  35. Long- and short-term effects of androgens in human umbilical artery smooth muscle
  36. Beyond the Limits of Oxygen: Effects of Hypoxia in a Hormone-Independent Prostate Cancer Cell Line
  37. Androgen-responsive and nonresponsive prostate cancer cells present a distinct glycolytic metabolism profile
  38. Six transmembrane epithelial antigen of the prostate 1 is down-regulated by sex hormones in prostate cells
  39. A new strategy for RNA isolation from eukaryotic cells using arginine affinity chromatography
  40. Amniotic membrane: from structure and functions to clinical applications
  41. STEAP Proteins: From Structure to Applications in Cancer Therapy
  42. A novel prokaryotic expression system for biosynthesis of recombinant human membrane-bound catechol-O-methyltransferase
  43. Impact of plasmid induction strategy on overall plasmid DNA yield and E. coli physiology using flow cytometry and real-time PCR
  44. Monitoring plasmid DNA induction strategies using multi-parameter flow cytometry and real-time PCR
  45. Regucalcin is under-expressed in human breast and prostate cancers: Effect of sex steroid hormones
  46. STEAP1 is over-expressed in breast cancer and down-regulated by 17β-estradiol in MCF-7 cells and in the rat mammary gland
  47. Characterization of oligoadenylate synthetase-1 expression in rat mammary gland and prostate: effects of 17β-estradiol on the regulation of OAS1g in both tissues
  48. Regucalcin is expressed in rat mammary gland and prostate and down-regulated by 17β-estradiol